Literature DB >> 15001598

Dynamics of serum cortisol levels after transsphenoidal surgery in a cohort of patients with Cushing's disease.

G A F S Rollin1, N P Ferreira, M Junges, J L Gross, M A Czepielewski.   

Abstract

Transsphenoidal pituitary surgery is the treatment of choice for Cushing's disease (CD). Despite the widespread acceptance of this procedure, there is no agreement regarding the definition of successful treatment. We prospectively studied postoperative serum cortisol dynamics in 41 patients with CD (including a total of 45 surgeries). The mean postoperative follow-up period was 4.8 yr. Remission was defined as clinical and laboratory signs of adrenal insufficiency, glucocorticoid dependence, and serum cortisol suppression on overnight oral 1-mg dexamethasone suppression test. Serum cortisol was measured preoperatively and postoperatively at 6, 12, and 24 h (28 surgeries) and at 10-12 d (45 surgeries). No statistical difference was detected in mean preoperative and 6-h postoperative cortisol levels between surgically induced remission patients [22.1 +/- 7.73 microg/dl (610 +/- 213.3 nmol/liter) and 25.2 +/- 19 microg/dl (695.2 +/- 524.4 nmol/liter)] and surgical failure patients [23.6 +/- 6.95 micro g/dl (651.4 +/- 161.8 nmol/liter) and 37.5 +/- 18.1 microg/dl (1035 +/- 499.6 nmol/liter); P = 0.50 and P = 0.17]. At 12 and 24 h after surgery, the difference was significant (P = 0.009 and P < 0.0001). Mean cortisol levels were 12.44 +/- 13.3 microg/dl (343.3 +/- 367.1 nmol/liter) and 4.72 +/- 6.72 microg/dl (130.3 +/- 185.5 nmol/liter) in the remission group and 26.3 +/- 7.06 microg/dl (725.9 +/- 194.8 nmol/liter) and 23.5 +/- 6.86 microg/dl (648.6 +/- 189.3 nmol/liter) in the failure group (P = 0.009; P < 0.0001). At 10-12 d after the procedure, the difference was also significant (P < 0.0001): cortisol levels were 2.52 +/- 3.32 microg/dl (69.5 +/- 91.6 nmol/liter) in the remission group and 24.9 +/- 13.3 microg/dl (687.2 +/- 367.1 nmol/liter) in the failure group. In conclusion, in the immediate postoperative period of transsphenoidal surgery, remission of CD is not necessarily defined by undetectable serum cortisol. During the first 10-12 d after surgery, cortisol nadir correctly classified the remission [cortisol, 7.0 microg/dl (193.2 nmol/liter) or less] and the failure groups [cortisol, 8.0 microg/dl (220.8 nmol/liter) or more]. Glucocorticoid should be administered only after laboratory and/or clinical evidence of adrenal insufficiency.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15001598     DOI: 10.1210/jc.2003-031170

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  23 in total

Review 1.  Characterization of persistent and recurrent Cushing's disease.

Authors:  Nina K Sundaram; Alessia Carluccio; Eliza B Geer
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

2.  Pituitary-adrenal dynamics after ACTH-secreting pituitary tumor resection in patients receiving no steroids post-operatively.

Authors:  F R Pimentel-Filho; M E R Silva; K C Nogueira; K Berger; A Cukiert; B Liberman
Journal:  J Endocrinol Invest       Date:  2005-06       Impact factor: 4.256

3.  Determinants of neurosurgical outcome in pituitary tumors.

Authors:  M J Barahona; L Sojo; A M Wägner; F Bartumeus; B Oliver; P Cano; S M Webb
Journal:  J Endocrinol Invest       Date:  2005-10       Impact factor: 4.256

4.  Recurrence of Cushing's disease preceded by the reappearance of ACTH and cortisol responses to desmopressin test.

Authors:  Chiara Dall'Asta; Laura Barbetta; Luigi Bonavina; Paolo Beck-Peccoz; Bruno Ambrosi
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

Review 5.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

6.  Recovery of the hypothalamic-pituitary-adrenal axis in children and adolescents after surgical cure of Cushing's disease.

Authors:  Maya Lodish; Somya Verma Dunn; Ninet Sinaii; Margaret F Keil; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2012-03-07       Impact factor: 5.958

7.  Pituitary tumor apoplexy in patients with Cushing's disease: endocrinologic and visual outcomes after transsphenoidal surgery.

Authors:  Osamah J Choudhry; Asad J Choudhry; Elkin A Nunez; Jean Anderson Eloy; William T Couldwell; Ivan S Ciric; James K Liu
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

Review 8.  Update on the medical management of pituitary adenomas.

Authors:  Cheryl A Pickett
Journal:  Curr Neurol Neurosci Rep       Date:  2005-05       Impact factor: 5.081

9.  Normalized Early Postoperative Cortisol and ACTH Values Predict Nonremission After Surgery for Cushing Disease.

Authors:  David Asuzu; Grégoire P Chatain; Christina Hayes; Sarah Benzo; Raven McGlotten; Meg Keil; Andrea Beri; Susmeeta T Sharma; Lynnette Nieman; Maya Lodish; Constantine Stratakis; Russell R Lonser; Edward H Oldfield; Prashant Chittiboina
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

10.  Delayed remission after transsphenoidal surgery in patients with Cushing's disease.

Authors:  Elena Valassi; Beverly M K Biller; Brooke Swearingen; Francesca Pecori Giraldi; Marco Losa; Pietro Mortini; Douglas Hayden; Francesco Cavagnini; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2010-01-15       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.